Skip to content

Reference information only. Therapept does not sell peptides and does not provide medical advice.Research-use notice

Therapept

Testing & documentation

HPLC vs LC-MS: What Each Test Actually Tells You

HPLC and LC-MS are not competing methods or tiers of the same measurement. They answer different questions — how much of one thing, and which thing — and a purity figure without an identity confirmation is a known blind spot.

Therapept EditorialUpdated 3 September 20268 min readReviewed by Therapept Editorial

These two methods are often listed side by side as though one were a stronger version of the other. They are not. They answer separate questions, and a documentation package built on only one of them has a predictable gap.

The short version

The short version
RP-HPLC with UV detectionLC-MS
Question answeredHow much of the detected material is the main component?What is the molecular mass of that component?
Primary outputChromatographic purity, as area %Observed mass, compared against expected mass
Separates componentsYes — this is its main strengthYes, the LC front end does the same separation
Confirms identityNo. Retention time alone is suggestive, not conclusiveYes, within the resolution of the instrument
Blind toAnything that does not absorb at the detection wavelength or does not eluteSpecies that do not ionise well under the chosen source conditions
Typical roleRoutine lot release and purity comparisonIdentity confirmation; characterising impurities

What HPLC measures, and where it stops

Reversed-phase HPLC separates components by hydrophobicity. A UV detector, usually near 214 nm where the peptide bond absorbs, records what elutes and when. Purity is reported as the main peak's share of total detected peak area.

The important limits follow directly from that description. The detector only sees what absorbs at the chosen wavelength. The column only reports what elutes within the run. And area percent is a ratio of detector response, not of mass — different components can produce different responses for the same amount of material.

  • Inorganic salts and many non-chromophoric residues do not appear at all.
  • Counterion content — trifluoroacetate is common after preparative purification — and residual water are not part of the figure.
  • A closely related impurity that co-elutes with the main peak is counted inside the main peak, not against it.
  • Retention time can support an identity assignment only when a known reference standard is run under identical conditions in the same sequence.

What LC-MS adds

Mass spectrometry measures mass-to-charge ratio. For peptides analysed by electrospray ionisation, the result is typically a series of multiply-charged ions that are deconvoluted into a molecular mass, which is then compared against the mass calculated from the intended sequence.

That comparison is what turns a pure peak into an identified compound. It is also what catches the failure modes purity alone cannot: a truncated sequence missing a residue, a deletion, an oxidation, or a substance that is simply something else.

Tandem MS goes further and fragments the molecule, producing sequence-level evidence rather than a single mass. It is the appropriate method when a mass alone would be ambiguous — for example when two candidate sequences share a molecular formula.

The analyses that answer different questions again

Purity and identity are two of several independent properties. Documentation that covers only those two is silent on the rest.

The analyses that answer different questions again
AnalysisQuestion it answers
Amino acid analysisHow much of the sample mass is actually peptide, rather than salt and water
Karl Fischer titrationHow much water is present
Ion chromatographyHow much counterion — trifluoroacetate, acetate — is present
Bacterial endotoxin test (LAL)Whether bacterial endotoxin is present above a stated limit
Sterility testingWhether viable organisms are recoverable under the compendial method
Residual solventsWhether solvents from synthesis remain above limits

What to request together

  • RP-HPLC purity with the full method — column, mobile phase, gradient, detection wavelength — and the chromatogram itself.
  • Mass confirmation with expected mass, observed mass, and the charge states or adducts used.
  • Net peptide content when comparing material on a mass basis.
  • Endotoxin or sterility results only if the specific test was performed; neither is implied by purity or identity.

Sources

  1. ICH Q2(R2) — Validation of Analytical Procedures
  2. FDA — Pyrogen and Endotoxins Testing: Questions and Answers
  3. FDA — Analytical Procedures and Methods Validation for Drugs and Biologics

This article is informational. It is not medical, legal or financial advice. Editorial policy · Report a correction